ResMed Aktie
218,80
EUR
-4,20
EUR
-1,88
%
256,57
USD
-0,13
USD
-0,05
%
Werbung
ResMed Aktie Analyse
| 25.09.17 | ResMed Underweight | Barclays Capital | |
| 07.04.16 | ResMed Underweight | Barclays Capital | |
| 27.01.15 | ResMed Under Perform | Northland Capital |
Werbung
Werbung